DNDi encourages and maintains the highest ethical standards in research. This means not just the avoidance of wrongdoing, but also rigor, carefulness, and accountability. All partners and persons engaged in research at DNDi are responsible for adhering to the highest standards. All of DNDi’s development work is executed according to ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use) guidelines. For all of its pre-clinical work, DNDi strictly follows all established regulatory guidelines. Clinical studies are conducted according to Good Clinical Practice (GCP) with products that comply with regulatory requirements.
Given DNDi’s commitment to the highest ethical standards in research, DNDi takes seriously allegations of research misconduct. Detailed information on this subject is available in our Research Misconduct Policy.